フォロー
Xiaowei Dong
Xiaowei Dong
確認したメール アドレス: unthsc.edu
タイトル
引用先
引用先
Current strategies for brain drug delivery
X Dong
Theranostics 8 (6), 1481, 2018
9222018
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
X Dong, RJ Mumper
Nanomedicine 5 (4), 597-615, 2010
3902010
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP
X Dong, CA Mattingly, MT Tseng, MJ Cho, Y Liu, VR Adams, RJ Mumper
Cancer research 69 (9), 3918-3926, 2009
3412009
Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia
P Ma, X Dong, CL Swadley, A Gupte, M Leggas, HC Ledebur, RJ Mumper
Journal of biomedical nanotechnology 5 (2), 151-161, 2009
2052009
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization
X Dong, CA Mattingly, M Tseng, M Cho, VR Adams, RJ Mumper
European journal of pharmaceutics and biopharmaceutics 72 (1), 9-17, 2009
1232009
Extracellular vesicles extracted from young donor serum attenuate inflammaging via partially rejuvenating aged T-cell immunotolerance
W Wang, L Wang, L Ruan, J Oh, X Dong, Q Zhuge, DM Su
The FASEB Journal 32 (11), 5899, 2018
692018
Efficient planar chiral 2′-substituted 1, 1′-P, N-ferrocene ligands for the asymmetric Heck reaction: control of enantioselectivity and configuration by planar chiral substituent
WP Deng, XL Hou, LX Dai, XW Dong
Chemical Communications, 1483-1484, 2000
592000
Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles
K Pham, D Li, S Guo, S Penzak, X Dong
Journal of Controlled Release 226, 88-97, 2016
492016
Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm
K Chaudhari, J Wang, Y Xu, A Winters, L Wang, X Dong, EY Cheng, R Liu, ...
PLoS One 15 (6), e0234571, 2020
452020
Curcumin nanoparticles and their cytotoxicity in docetaxel-resistant castration-resistant prostate cancer cells
I Tanaudommongkon, A Tanaudommongkon, P Prathipati, JT Nguyen, ...
Biomedicines 8 (8), 253, 2020
372020
Enantioselective hydrolysis of various substituted styrene oxides with Aspergillus Niger CGMCC 0496
H Jin, Z Li, XW Dong
Organic & Biomolecular Chemistry 2 (3), 408-414, 2004
372004
The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase
X Dong, RJ Mumper
Drug development and industrial pharmacy 32 (8), 973-980, 2006
362006
Nanoparticle compositions comprising liquid oil cores
RJ Mumper, X Dong
252010
Current Status of In vitro Models of the Blood-brain Barrier
B Shah, X Dong
Current drug delivery 19 (10), 1034-1046, 2022
242022
Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability
S Guo, K Pham, D Li, SR Penzak, X Dong
International Journal of Nanomedicine, 1451-1460, 2016
192016
Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution
P Prathipati, J Zhu, X Dong
European Journal of Pharmaceutics and Biopharmaceutics 108, 126-135, 2016
152016
The stability of quetiapine oral suspension compounded from commercially available tablets
J Tran, MA Gervase, J Evans, R Deville, X Dong
PLoS One 16 (8), e0255963, 2021
112021
Anticancer efficacy of oral docetaxel nanoformulation for metronomic chemotherapy in metastatic lung cancer
S Le, CM Chang, T Nguyen, Y Liu, YA Chen, E Hernandez, P Kapur, ...
Journal of biomedical nanotechnology 16 (5), 583-593, 2020
82020
Preparation and characterization of novel HDL-mimicking nanoparticles for nerve growth factor encapsulation
J Zhu, X Dong
Journal of Visualized Experiments: Jove, 55584, 2017
82017
Design and evaluation of two-step biorelevant dissolution methods for docetaxel oral formulations
B Shah, X Dong
AAPS PharmSciTech 23 (5), 113, 2022
52022
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20